Volume 29, Number 5—May 2023
CME ACTIVITY - Research
Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021
Figure 2
![Assessment of emm type, infection source, and IVDU history of patients with invasive group A Streptococcus infection in this study, West Virginia, USA, 2020–2021. Anatomic source of infection and the status of patient IVDU history is shown corresponding to emm type. Size of the colored sections indicates the relative number of isolates per emm type. IVDU, intravenous drug use; SSTI, skin and soft tissue infection.](/eid/images/22-1421-F2.jpg)
Figure 2. Assessment of emm type, infection source, and IVDU history of patients with invasive group A Streptococcus infection in this study, West Virginia, USA, 2020–2021. Anatomic source of infection and the status of patient IVDU history is shown corresponding to emm type. Size of the colored sections indicates the relative number of isolates per emm type. IVDU, intravenous drug use; SSTI, skin and soft tissue infection.
1These senior authors contributed equally to this article.
Page created: March 06, 2023
Page updated: April 14, 2023
Page reviewed: April 14, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.